We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
An army of enterprises sought for IPO at Hong Kong, S.A.R., China in the almost first half of 2021. Not long ago, a prospectus submitted by Beijing Advaccine Biotechnology (hereinafter, "Advaccine") for listing caused a sensation, and the launch of its co